Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Lane

Showing results (121-130 of 265) with videos related to

Pageof 27
Sort By:
Thrombosis Research|April 15, 1982
Clearance of human desaminotyrosyl fibrinopeptide A from the rat circulation: role of kidney and proteolytic enzymesD A Lane, M Siodlak, E Thompson, et al.
Thrombosis Research|December 15, 1982
Two more abnormal fibrinogens (London III and Sydney) with impaired fibrinopeptide releaseD A Lane, H Ireland, E Thompson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparinE Anastassiades, H Ireland, A Flynn, et al.
Thrombosis Research|April 1, 1976
Fibrinogen subunit degradation in vitro: studies on human fibrinogen heterogeneityM F Scully, D A Lane, D P Thomas, et al.
Biochemical and Biophysical Research Communications|February 23, 1976
Role of subunit crosslinking in fibrin solubilityM F Scully, D A Lane, M K Dubiel, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Amine inhibition of fibrin cross-linkingM K Dubiel, M F Scully, D A Lane, et al.
British Journal of Haematology|December 1, 1978
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulationD A Lane, F E Preston, M E VanRoss, et al.
Haemostasis|January 1, 1986
On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failureD A Lane, A Flynn, H Ireland, et al.
The Biochemical Journal|August 15, 1989
Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombinB Bray, D A Lane, J M Freyssinet, et al.
The Biochemical Journal|March 15, 1984
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4D A Lane, J Denton, A M Flynn, et al.
Pageof 27

Showing results (121-130 of 265) with videos related to

Sort By:
Pageof 27
Thrombosis Research|April 15, 1982
Clearance of human desaminotyrosyl fibrinopeptide A from the rat circulation: role of kidney and proteolytic enzymesD A Lane, M Siodlak, E Thompson, et al.
Thrombosis Research|December 15, 1982
Two more abnormal fibrinogens (London III and Sydney) with impaired fibrinopeptide releaseD A Lane, H Ireland, E Thompson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparinE Anastassiades, H Ireland, A Flynn, et al.
Thrombosis Research|April 1, 1976
Fibrinogen subunit degradation in vitro: studies on human fibrinogen heterogeneityM F Scully, D A Lane, D P Thomas, et al.
Biochemical and Biophysical Research Communications|February 23, 1976
Role of subunit crosslinking in fibrin solubilityM F Scully, D A Lane, M K Dubiel, et al.
Thrombosis Et Diathesis Haemorrhagica|November 15, 1975
Proceedings: Amine inhibition of fibrin cross-linkingM K Dubiel, M F Scully, D A Lane, et al.
British Journal of Haematology|December 1, 1978
Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulationD A Lane, F E Preston, M E VanRoss, et al.
Haemostasis|January 1, 1986
On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failureD A Lane, A Flynn, H Ireland, et al.
The Biochemical Journal|August 15, 1989
Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombinB Bray, D A Lane, J M Freyssinet, et al.
The Biochemical Journal|March 15, 1984
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4D A Lane, J Denton, A M Flynn, et al.
Pageof 27